U.S. Dairy Industry Shifts to High-Protein Products Amid GLP-1 Drug Demand

The rapid adoption of GLP‑1 weight‑loss medications is driving U.S. consumers to seek more protein and fiber, prompting dairy processors to invest heavily in high‑protein milk, yogurt and other specialty products. Market analyst Shawn Hackett warns that producers who can quickly adapt their herds and processing to supply the higher‑protein milk needed by processors stand to gain stronger returns, while those that continue with traditional milk may see reduced profitability.

At the same time, a cyberattack forced Coca‑Cola to pause production at several Fairlife facilities, underscoring growing cybersecurity risks to the food supply chain. The incident has led experts to call for increased domestic and regional dairy production to mitigate such vulnerabilities.